Preliminary Programme


 Thursday, June 15, 2023
08:00-09:30 REGISTRATION
09:30-10:15 WELCOME & OPENING REMARKS
  • Ioanna Koukli, HBio President; Founder & CEO Pharmassist Ltd, Greece
  • Sophia Kounenaki-Efraimoglou, President, Athens Chamber of Commerce & Industry (ACCI), Greece
  • Nektarios Tavernarakis, Chairman, Foundation for Research & Technology; Research Director, Institute of Molecular Biology & Biotechnology, FORTH, Crete, Greece
  • Georgios Skretas, Director, Institute for Bio-innovation, Biomedical Sciences Research Center “Alexander Fleming”, Greece
  • Efstathios Gonos, General Director, Hellenic Pasteur Institute, Greece
  • George Vasilopoulos, Executive Consultant, Hellenic Union of Pharmaceutical Industry (PEF), Greece
  • Maggie Athanassiadi, Director, Industry, Development, Technology & Innovation Division, SEV Hellenic Federation of Enterprises, Greece
  • Dimitris Kletsas, Vice-President National Centre for Scientific Research “Demokritos”; Director, Institute of Biosciences & Applications (IBA), Greece
  • Thomas Bartzanas, Vice Rector, Research, Finance & Development, Agricultural University Athens; Director, Lab of Farm Structures, Agricultural University of Athens, Greece
10:15-12:15 KEYNOTE SESSION 1: The vision of the Biotechnology & Life Sciences sector: Opportunities & challenges
Chairperson: TBA

Panelists:
  • Alexis M. Kalergis, Director, Millennium Institute on Immunology & Immunotherapy Pontificia Universidad Católica de Chile, Chile
  • Spyros Artavanis-Tsakonas, President, National Council for Research, Technology & Innovation (ESETEK); Professor Emeritus of Cell Biology; Faculty Member, Harvard Medical School's Cell Biology Department, USA
  • Michel Vounatsos, Former CEO Biogen Inc.; Director of PerkinElmer since 2020, Chair of the nominating & governance committee; Director, Zai Lab Ltd since 2023, Chair of the commercial committee & member of the research and development committee; Entrepreneur, USA
  • Alexis M. Kalergis, Director, Millennium Institute on Immunology & Immunotherapy Pontificia Universidad Católica de Chile, Chile

More Speakers to be confirmed

12:15-14:15 NETWORKING LUNCH - EXHIBITION BOOTH PRESENTATIONS - B2B MEETINGS
14:15-17:00 KEYNOTE SESSION 2: Bridging the Gap from Research to Commercialization
 Chairperson: Georges Kotrotsios, Technology Advisor Roumai Medical; Member, Industrial Advisory Board, Swiss Academy of Engineering Sciences, Switzerland

Speakers:
14:15-14:35 Barriers and Accelerators for new biomedical spinouts
Mike Romanos, Assoc. Dean, Enterprise, Faculty of Medicine, Imperial College, London, UK
14:35-14:55 TBA
Nikos Stergiopoulos, CEO Rheon Medical, Lausanne, Switzerland
14:55-15:15 Building impactful innovation ecosystems
Lysimachos Zografos, Entrepreneur-in-Residence (Wellcome Trust), University of Edinburgh, Scotland
15:15-15:35 Breaking Barriers: Filling the Missing Gap
Christian Duchow, Director – Founder The BioArte Ltd & The Materia Company Ltd, Greece
15:35-15:55 The Role of Medical Affairs bridging between science and value in General & How can Big Pharma support and accelerate speed to market for Biotech Start ups
Gerald Panday, Head of Medical Europe, Canada & Thrombosis Franchise; Global Medical Affairs, LEO Pharma, Denmark
15:55-16:15 TBA
Pantelis Tzortzakis, Executive Vice Chairman, Hellenic Development Bank, Greece
16:15-16:35 How the smartHEALTH European Digital Innovation Hub assists towards the creation of usable data spaces
Dimitrios Katehakis, Head, Center for eHealth Applications& Services
FORTH, Institute of Computer Science, Greece
16:35-16:55 Discussions & Q&A’s
17:00-18:30 NETWORKING DRINKS - EXHIBITION BOOTH PRESENTATIONS - B2B MEETINGS
 Friday, June 16, 2023
08:30-10:00 GREEK BIOPHARMA INNOVATION: Your changing world with the new EU Pharma Legislation
EU pharma legislation is going to change your business. What you make, where and how you sell it, and whether your business model is even viable.
The European Commission published new legislative proposals in April that will redefine the business model of biotechnology in Europe. In trying to bring medicines to more patients, the legislation proposals reduce data protection, limit exclusivity for orphan medicines and brings heavy pressure to launch in all 27 Member States within two years of EMA approval.
Changing the rule book that has helped build Europe’s small company ecosystem over the last 20 years is going to have consequences for start-ups, those seeking scale up investment, clinical trials and companies going to market, often for the first time.
This session/panel, chaired by EuropaBio, presents the key impacts points for biotechnology innovation within Greece, with contributions from small and large companies and policy makers – bring your voice to the discussion for the future of your own science.

Chairperson: Claire Skentelbery, Director General EuropaBio, Belgium

Panelists:
  • Hardy Rideout, Co-founder & CSO, Anacalypsis Therapeutics, Greece
  • Georgios Drakakis, CEO, Purposeful, Greece
  • Kostas Papagiannis, Country President & Managing Director, Novartis Hellas, Greece
  • Michael Chimonas, General Manager, Hellenic Association of Pharmaceutical Companies, Greece
10:00-12:00 KEYNOTE SESSION 3: The role of clinical research in supporting disruptive innovation  

Chairperson: Nassos Alevizopoulos, Senior Scientific Advisor, Pharmassist Ltd, Greece

Speakers:
10:00-10:20 Breakthrough Innovation in Rare Disease:  Opportunities and Challenges
Angelos Stergiou, President & CEO SELLAS Life Sciences Group, USA
 10:20-10:40 Focused Case Study from a Project Management Lens: The real cost of doing business
Sariah Ramoutar-Persaud, Executive Director, Clinical Operations, INC., USA
10:40-11:00
Early phase clinical trials in Greece: the case of the Clinical Research Unit at the Aristotle University School of Medicine
George Papazisis, Professor Clinical Pharmacology, Psychiatrist & Clinical Pharmacologist, Medical Director, Clinical Research Unit, School of Medicine, Aristotle University Thessaloniki, Greece
 11:00-11:20 How we can locally enhance clinical research and promote innovation
Manos Koutalas, Medical Affairs Director, Janssen Greece-Cyprus-Malta
11:20-11:40
Boundless Mass Spectrometry Measurements in Biomedical Sciences; A driver for the Discovery and Development of novel therapeutics
Konstantinos Tamvakopoulos, Research Director, Researcher A‘ Center for Clinical, Experimental Surgery & Translation Research; Head of Pharmacology Laboratory, Institute of Biomedical Research, Academy of Athens, Greece
11:40-12:00 Discussions & Q&A’s
12:00-14:00 NETWORKING LUNCH - EXHIBITION BOOTH PRESENTATIONS - B2B MEETINGS
14:00-16.30 KEYNOTE SESSION 4: Investment Opportunities for Disruptive Innovation  
Round table discussions involving major EU investment stakeholders (VCs, Angel Investors, Financial Institutes)

Chairperson: Elias Papatheodorou, Board Chair, HepaRegeniX (Germany) & Memo Therapeutics (Switzerland); Board member, Tribune Therapeutics, Sweden

Speakers:
  • Maria Hala, Senior Business & Strategic Development Advisor / Angel Investor, Greece
  • Aristos Doxiadis, Partner, Big Pi Ventures, Greece
  • Valeri Petrov, Partner, Eleven Ventures, Bulgaria
  • Sofia Ioannidou, Partner, Andera Partners, France
  • Elias Eliades, Director, Investment Promotion, Enterprise Greece
  • Antigoni Lymperopoulou, Chief Executive Officer, Hellenic Development Bank of Investments (HDBI), Greece
16:30-18:30 EXHIBITION BOOTH PRESENTATIONS & B2B MEETINGS
 Saturday, June 17, 2023
09:30-11:30 Personalized Medicine - Innovative approaches to Tailoring Disease Prevention and Treatment
Chairperson: Stamatiki Kritas, Business Development Manager HBio
  • The MEDIC NEST project: A collaborative initiative of 4 EU clusters
  • Hellenic Molecular Oncology Network
  • Greek National Network of Precision Medicine in Cardiology and the Prevention of Sudden Death
  • Hellenic Precision Medicine Network on Neurodegenerative Diseases
  • The Greek Research Infrastructure for Personalized Medicine
  • The New Human Genome Institute, FORTH
11:30-12:00 MORNING TEA & NETWORKING
12:00-14:00 WORKSHOP FOR STARTUPS
14:00-15:00 NETWORKING LUNCH
15:00-17:00 PITCH YOUR IDEA
17:00-18:00 NETWORKING DRINKS - FINAL REMARKS - ANNOUNCEMENT OF WINNERS



Proudly Supported by:




This event is organized under the framework of the MEDIC-NEST project aiming to enhance collaboration between European clusters and their members in the field of precision medicine.